14T179: Abstracts: Vasculitis – Non-ANCA-Associated & Related Disorders II: Clinical (2557–2562)

Presenting Author(s)

• 

  Shubhasree Banerjee, MD, MBBS

  University of Pennsylvania
  Philadelphia, PA, United States

  Disclosure information not submitted.
• AC

  Adrien Cottu, MD, -None-

  Sorbonne Université
  Boulogne-Billancourt, France

  Disclosure information not submitted.
• MK

  Mahmut Kaymakci, MD

  Mayo Clinic
  Rochester, MN, United States

  Disclosure information not submitted.
• FL

  Fernando López-Gutierrez, PhD

  Rheumatology, Hospital Universitario Marqués de Valdecilla
  Santander, Spain

  Disclosure information not submitted.
• DN

  Desh Nepal, MBBS, FACP

  Medical College of Wisconsin, Milwaukee
  Pewaukee, WI, United States

  Disclosure information not submitted.
• AT

  Alessandro Tomelleri, MD

  IRCCS San Raffaele Hospital, Milan, Italy
  Milano, Milan, Italy

  Disclosure information not submitted.

Abstract oral session.

Non-CME

Presentations:

• 4:00 PM - 4:10 PM PT

  Clinicopathologic Features of Patients with Giant Cell Arteritis and Thoracic Aorta Repair: A Single Center Experience over Two Decades
  

  Presenting Author: Mahmut Kaymakci, MD – Mayo Clinic
• 4:10 PM - 4:15 PM PT

  Q&A
  
• 4:15 PM - 4:25 PM PT

  Aortic Aneurysms in a Multicenter Cohort of 196 Patients with Aortitis Related to Giant Cell Arteritis Treated with Tocilizumab
  

  Presenting Author: Fernando López-Gutierrez, PhD – Rheumatology, Hospital Universitario Marqués de Valdecilla
• 4:25 PM - 4:30 PM PT

  Q&A
  
• 4:30 PM - 4:40 PM PT

  Clinical Manifestations and Immunomodulatory Treatment in Patients with Relapsing Polychondritis
  

  Presenting Author: Shubhasree Banerjee, MD, MBBS – University of Pennsylvania
• 4:40 PM - 4:45 PM PT

  Q&A
  
• 4:45 PM - 4:55 PM PT

  Risk of Gastrointestinal Perforation Among Patients with Giant Cell Arteritis Who Received Tocilizumab
  

  Presenting Author: Desh Nepal, MBBS, FACP – Medical College of Wisconsin, Milwaukee
• 4:55 PM - 5:00 PM PT

  Q&A
  
• 5:00 PM - 5:10 PM PT

  The Prognostic Value of the “2022 ACR/EULAR Classification Criteria for Giant Cell Arteritis”: Data from the Italian Society of Rheumatology Vasculitis Study Group
  

  Presenting Author: Alessandro Tomelleri, MD – IRCCS San Raffaele Hospital, Milan, Italy
• 5:10 PM - 5:15 PM PT

  Q&A
  
• 5:15 PM - 5:25 PM PT

  Immune Checkpoint Inhibitors-Induced Large Vessel Vasculitis: Data from a Multicenter Study
  

  Presenting Author: Adrien Cottu, MD, -None- – Sorbonne Université
• 5:25 PM - 5:30 PM PT

  Q&A